Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaY L Kasamon, R J Jones, R A Brodsky, et al.Journal of Hematotherapy|May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftmentS J Noga, A Seber, J M Davis, et al.Bone Marrow Transplantation|December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignanciesP V O'Donnell, R J Jones, G B Vogelsang, et al.Leukemia|August 27, 2010
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemiasS Morisot, A S Wayne, O Bohana-Kashtan, et al.Bone Marrow Transplantation|November 4, 2008
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimenJ Bolaños-Meade, L Luznik, M Muth, et al.Experimental Hematology|November 8, 2001
The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemiaC B Miller, P A Rowlings, M J Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
Long-term results of blood and marrow transplantation for Hodgkin's lymphomaG Akpek, R F Ambinder, S Piantadosi, et al.Neuroimage|November 15, 2021
Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality dataC Maffei, C Lee, M Planich, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.Investigational New Drugs|April 30, 2015
AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studiesA Omlin, R J Jones, R van der Noll, et al.Pageof 21